Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Acute Lymphoblastic Leukemia research, and Cancer Genomics and Diagnostics.
Evaporation‐Induced Composition Evolution in Metal Additive Manufacturing (Adv. Funct. Mater. 7/2025)
Association of Ticagrelor Metabolic SNPs With Adverse Drug Reactions in Patients With Acute Coronary Syndrome.
Impact of DUSP22 and TP63 rearrangements in patients with ALK-negative ALCL treated with frontline BV-CH(E)P
Evaporation‐Induced Composition Evolution in Metal Additive Manufacturing
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial
Consolidation Therapy with Blinatumomab Improves Overall Survival in Newly Diagnosed Adult Patients with B-Lineage Acute Lymphoblastic Leukemia in Measurable Residual Disease Negative Remission: Results from the ECOG-ACRIN E1910 Randomized Phase III National Cooperative Clinical Trials Network Trial
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
Efficacy of Moxibustion Smoke for Stage 1 Post-Stroke Shoulder-Hand Syndrome: Protocol for a Multi-Center, Single-Blind Randomized Sham-Controlled Trial [Letter]
Dove Medical Press (Taylor and Francis Group) 2022cited by 0position: middle
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Molecular classification improves risk assessment in adult <i>BCR-ABL1–</i>negative B-ALL
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
High resolution copy number inference in cancer using short-molecule nanopore sequencing
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Accelerated single cell seeding in relapsed multiple myeloma
Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models